Mealey's (October 14, 2022, 7:48 AM EDT) -- WASHINGTON, D.C. — Two weeks after the U.S. solicitor general (SG) submitted an amicus curiae brief recommending that certiorari be denied in a dispute over the enablement requirement in patent specifications, petitioner Amgen Inc. filed a supplemental brief, suggesting that the SG did not fully address the key issues raised in its petition and reiterating its contention that important questions regarding the scope and nature of enablement need to be addressed by the U.S. Supreme Court....